Scientist Solutions: Life Science Discussions
 Refer a Friend    Link To Us    Bookmark Us       

      
 » Home » Microbiology » Antimicrobials and Vaccines » CHI Novel Vaccines

Other Topics
12/1/2008 01:45 PM
Antimicrobials and insect ...
12/7/2007 04:13 PM
Disinfection and Steriliz ...
5/26/2005 09:27 PM
AIDS[color=tomato][/color ...
1/6/2005 03:34 PM
HIV Vaccines
Subscribet to topic
  Add New Topic  Add New Poll
bottom of page RSS Feed 

Topic Feed

 

CHI Novel Vaccines

 [View Printable]
Tony Rook

Moderator

See
Similar
Scientists



View Blogs


Group: Member
Posts: 581
Joined: Nov 03, 2005







 Send a personal messsage to Tony Rook Reply with a quote from this post Go to the top of the page

Overview

Novel Vaccines show promise for protecting humanity from the scourge of disease, yet their worth is not always appreciated by the public, leading to shortfalls in funding and product. This meeting features talks from leading innovators in the field of vaccines, ranging from cutting-edge research to breakthroughs in transporting and administering vaccines throughout the world. Solutions will be presented that overcome the previous limitations of producing vaccine in embryonated chicken eggs. Novel Vaccines: Bridging Research, Development, and Production will focus on a New Wave of vaccines for the 21st century.
Sessions Include:

Day 1: Research: Meeting Medical Needs

* Overcoming Challenges
* Discovering Solutions
* Vaccine Breakthroughs

Day 2: Development: Transforming Concept into Product

* Promising Development
* Enhanced Magnitude
* & Functionality Immunomodulators/Adjuvants
* Autologus Cell Technologies
*

Day 3: Production: Heading to Market

* Vaccine Production Logistics
* Readying Vaccines for Market
* Bringing Needed Vaccines to Patients Around The World
* Novel Methods for Administering Vaccines

Keynote Presentations:

New Vaccine Technologies: A Regulatory Perspective
Jon R. Daugherty, Ph.D., U.S. Public Health Service, Senior Regulatory Review Officer, Office of Vaccines Research and Review, CBER / FDA

NIAID's Role in Influenza Vaccine Development
David S. Cho, Ph.D., M.P.H., Influenza Product Development Program Officer, Influenza,
SARS, & Related Viral Respiratory Diseases Section, NIAID / NIH
Featured Speakers:

Human Respiratory Virus Diseases and Vaccine Prospects
Richard Spaete, Ph.D., Senior Director, Research, MedImmune Vaccines, Inc.

Development of a Production Process for an ALVAC Vaccine Candidate
Kim Wong, Ph.D., Director, Cell & Viral Culture, Process Development, sanofi pasteur Ltd.

Adjuvanting DNA Vaccines
David B. Weiner, Ph.D., Chair, Gene Therapy and Vaccines Program, CAMB, Department of Pathology, University of Pennsylvania School of Medicine

For more information, please contact:
Mary Ruberry, Conference Producer
Phone: 617-630-1321 E-mail: mruberry@healthtech.com

For exhibit and sponsorship information, please contact:
Suzanne Carroll, Manager, Business Development
Phone: 617-630-1352 E-mail: scarroll@healthtech.com

.........................
Tony Rook

 Posted May 01, 2006, 16:57 PM
top of page   Add New Topic  Add New Poll

Forum Jump